The AIM Attraction


Contrary to popular belief, both institutional and private investors do have huge pots of cash for the right companies looking to IPO. 

In this article, Mark Fahy and Marcus Stuttard of the London Stock Exchange talk to Criticaleye about AIM’s enduring strength through the economic downturn and why it can be the perfect home for growth businesses needing an injection of capital.

The article also includes Community Comment from AIM veterans Clive Ansell, Robert Drummond and Faisal Rahmatallah

Share this with your Community


Contributors
Clive Ansell
Non-Executive Director
Eckoh plc
Marcus Stuttard
Head of AIM and UK Primary Markets
London Stock Exchange Group
Mark Fahy
Former Head of UK Small & Mid-Cap Companies

Robert Drummond
Chairman & Non-executive Director
North East Finance


Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

BLOG | Alignment at the Top

At our recent Growth Company Retreat, one theme came through consistently across discussions with executives and non-executive directors of high growth business leaders: strategy alone is not enough, alignme...


Criticaleye Asia Podcast - Chairing for Impact: Leadership Lessons from Ray Ferguson, Global Board Chair

In this episode, Yu-Wen Hsiao, Marketing and Communications Manager, APAC at Criticaleye, speaks with Ray Ferguson, Global Board Chair and seasoned international banker, shares his perspective on how CEOs and Boards ...


Click here to download this insight

BLOG | A Long-term View of the Business Landscape

Last week, we hosted a Leadership in the Boardroom Dinner: A Long-term View of the Business Landscape, bringing together Board members and senior executives to discuss the economic, technological and geopolitical for...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 137




Rolls-Royce British Land Drax Group plc Lightsource bp Mayborn Group London Stock Exchange Group Hitachi Solutions Aldermore Group AlixPartners GlaxoSmithKline plc LACE Partners NATS E.ON UK Legal & General Canaccord Genuity Group Inc NatWest Group Worldpay